Stem Cell Therapy Market Size 2024-2028

The stem cell therapy market size is estimated to grow by USD 16.67 billion at a CAGR of 18.69% between 2023 and 2028. With increasing advances in science and technology, consciousness has also increased. However, the knowledge is limited to aspects such as the high cost and adverse effects of regenerative medicine and not scientific facts. The cost is only addressed in developing countries where large insurers provide incentives to employers to send patients abroad. In certain countries with universal healthcare coverage, individuals may be paid by the government to be treated in other countries. These steps improve patient accessibility, making stem cells a more feasible option. This has led to the development of stem cell banking in which patients travel to countries that do not have strict regulatory restrictions.

What will be the size of the Market during the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation

By Application 

The market share growth by the cancer segment will be significant during the forecast period. Cellular therapies, including cellular health screening, are given to boost the ability of a patient's immune system to ability to fight cancer. They are made by taking a specific set of cells from the patient blood, they were altered and then administered back to the patient so that they would be more effective in attacking cancer cells.

Get a glance at the market contribution of various segments View a PDF Sample

The cancer segment was valued at USD 2.96 billion in 2018. Stem cell therapy for cancer treats blood-related diseases like non-Hodgkin lymphoma, Hodgkin lymphoma, multiple myeloma, and leukemia. The market is expected to grow over the forecast period, owing to the increased use of cell therapy for cancer. These factors will drive the growth of the global market during the forecast period.

By Type 

Allogeneic transplants are preferred more than autologous transplants as the scaling-up process is less complex than autologous, and they are financially viable. These transplants are preferred by patients as well as physicians and, thus, have a significant market share in the global market. Allogeneic transplantation is immunosuppressive and can repair tissues, in particular mesenchymal stem cells. Hence this transplantation elicits only a lower or weakened immune response upon implantation. Hence, they pose as a promising cell therapy. These factors will drive the growth of the global market during the forecast period.

By Region

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America occupies the largest share of the market. The US and Canada are the leading revenue contributors due to advanced facilities for stem cell isolation and storage. Also, efforts by the US federal authorities to regulate the US stem cell market have also increased the market growth of approved brands. Further, the increasing funds from government and private organizations will foster the development of stem cell therapies. The funding will contribute to the growth of the market in the region during the forecast period.

Buy Now Full Report and Discover More

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Athersys Inc. - The company offers stem cell therapies such as MultiStem products.

• Becton Dickinson and Co.
• Brainstorm Cell Therapeutics Inc.
• Bristol Myers Squibb Co.
• CRISPR Therapeutics AG
• Cynata Therapeutics Ltd.
• Cytori Therapeutics Inc.
• FUJIFILM Corp.
• Gamida Cell Ltd.
• Johnson and Johnson
• Lonza Group Ltd.
• Mesoblast Ltd.
• Novartis AG
• Pfizer Inc.
• Pluristem Therapeutics Inc.
• ReNeuron Group plc
• STEMCELL Technologies Inc.
• Takeda Pharmaceutical Co. Ltd.
• Thermo Fisher Scientific Inc.
• Vericel Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics

Umbilical stem cell therapy offers promising avenues for treating various medical conditions, including wounds, injuries, and neurologic disorders. LifeCell, a key player in the field, facilitates access to therapy through financial assistance programs, aiding individuals with lung dysfunction and chronic disorders. Allogenic stem cell therapy, employed for conditions like musculoskeletal disorders and cardiovascular diseases, avoids invasive surgeries, harnessing the potential of mesenchymal stem cells (MSCs). These therapies are administered in hospitals and specialized cell therapy production facilities, with a focus on precision medicine and personalized treatment approaches. Clinical trials explore the efficacy of the therapy in cancer patients and individuals with chronic injuries, fostering innovation and advancing the realm of personalized medicines for chronic disorders and immune system-related ailments. 

Omidubicel, derived from the mesoderm, shows promise in treating non-cancerous disorders such as carpal tunnel syndrome, cartilage repair, and ligament repair within the realm of orthopedic regenerative medicine. This therapy targets muscle and adipose-ASCs to address orthopedic implant failure and enhance recovery outcomes in patients suffering from these conditions. Wounds and injuries often necessitate advanced medical attention. Service companies play a vital role in providing healthcare solutions through efficient distribution channels like direct tenders or third-party distributors. Organizations like the World Health Organization monitor healthcare indices, focusing on liver, bone, and cartilage diseases, spurring R&D investments for central nervous system treatments and shaping the healthcare price index. 

Key Market Driver

The surge in chronic diseases globally is fueling the expansion of the market. Chronic conditions like heart disease, diabetes, stroke, cancer, obesity, and arthritis are increasingly prevalent, posing significant burdens on individuals and healthcare systems. A substantial portion of the global population is affected by one or more chronic ailments, with a quarter of adults enduring two or more such conditions.

Furthermore, chronic diseases often lead to tissue or organ damage, necessitating therapies focused on symptom management rather than cure. As a result, there's a growing adoption of cell therapies for chronic disease treatment, propelling the growth of the global market. This trend is expected to persist and drive further market expansion in the forecast period.

Significant Market Trends

The rise in costs of the transplantation is a key trend in market growth.  Transplanting of stem cells is expensive as it requires high levels of specialized equipment and resources. The difference in the conditioning regimen and the type of transplant decide the cost of the transplantation. The median healthcare cost for allogeneic hematopoietic transplants was generally higher than for autologous ones.

However, the main cost factor in the case of autologous cell therapy arises from the fact that each individual has to undergo screening and testing, and stem cells have to be isolated and harvested in individual batches. In allogeneic transplantation, screening is done once to find suitable donors, and then a cell bank system can be created. These factors will positively impact the growth of the global market during the forecast period.

Major Market Challenges

The safety concerns from stem cell therapy are a major challenge in market growth. There are various factors that contribute to the varying degrees of side effects experienced with stem cell therapy. In some patients, the side effects may be acute, developing immediately after transplantation. In others, they may be chronic, developing after a month or 100 days. 

However, transplanted tissue may be rejected by the host immune system, posing safety concerns. Aggressive induction therapy is the current methodology used to prevent acute rejection. However, it does not guarantee long-term graft survival and may also result in an increased risk of infections. These factors will hinder the growth of the global market during the forecast period.

Buy Now Full Report and Discover More

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.

• Application Outlook 
  • Cancer
  • Musculoskeletal disorder
  • Cardiovascular disease
  • Others

• Type Outlook 
  • Allogeneic transplants
  • Autologous transplants

• Region Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • ROW
    • Austrailia
    • Argentina
    • Rest of the World

Market Analyst Overview

The market is witnessing significant advancements and adoption, offering treatment options for a wide array of medical conditions. Stem cells, sourced from placental and umbilical cord blood, are utilized in therapies such as allogenic and autologous stem cell therapy. These treatments target various health issues, including musculoskeletal disorders, wounds, injuries, cardiovascular diseases, and gastrointestinal diseases. Stem cell therapy finds application in hospitals, surgical centers, and therapeutic companies, distributed through direct tenders or third-party distributors. As research and development investments surge, precision medicine, Allogenic type stem cell therapy and clinical trials expand, benefiting cancer patients and individuals with chronic disorders. However, challenges persist, including high costs, ethical concerns surrounding embryonic stem cells, and the need for technological advancements in stem cell banking and personalized medicines. Despite hurdles, the market continues to grow, driven by advancements in tissue engineering, regenerative medicine, and the emergence of innovative therapies.

Further, the field of regenerative medicine has witnessed remarkable advancements in utilizing stem cells for therapeutic purposes. Umbilical stem cells, derived from umbilical cord blood, hold immense potential in treating a wide range of conditions, including wounds, injuries, Invasive surgery, and various diseases. Allogenic stem cell therapy, involving the transplantation of cells from a donor, is increasingly employed in surgeries and medical procedures. These therapies target conditions such as cerebrovascular diseases, neurological disorders, autoimmune disorders, and spinal cord injuries. Research and development investments have fueled breakthroughs in treating conditions like Parkinson's disease, ALS, and stroke recovery. Moreover, technological advancements have facilitated the development of cell therapy production facilities, offering cost-effective solutions for patients. Private vendors, NGOs, and organizations like the National Stem Cell Foundation contribute to advancing regenerative medicine, offering hope for patients with chronic injuries and disorders.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the market growth and forecasting of the market between 2024 and 2028
• Precise estimation of the size of the market size and its contribution to the parent market
• Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
• Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
• Thorough market growth analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch